Ultima is putting a new spin on sequencing
Visit our experts at booth #3841 to learn how the UG 100™ sequencer offers a cost-effective and extremely low-error sequencing profile to support assays that require large amounts of high-fidelity sequencing data. With the recent launch of the Solaris portfolio of product advancements, Ultima has now increased sensitivity of variant detection with 5x yield improvements for the SNVQ60 ppmSeq™ mode enabling 30X coverage from as little as 2 nanograms of DNA, making the UG 100 a strong fit for applications like liquid biopsy that require finding a “needle-in-the haystack.”
Inocras Spotlight Session
Advancing Oncology Research and Minimal Residual Disease Detection with Inocras' Whole Genome Cancer Platform
- Time: 3:00 PM - 4:00 PM EST
- Speaker: Ariel Jaimovich, PhD VP - Applications at Ultima Genomics
- Location: Spotlight Theater B
Erin Connolly-Strong, MD – Chief Medical Officer, Inocras Inc.
YoungSeok Ju – Co-founder, Inocras Inc.
Majd Al Assaad, MD – Sr. Research Fellow, Weill Cornell Medicine
Ariel Jaimovich, PhD – VP of Applications, Ultima Genomics